Cyclic MOG₃₅–₅₅ ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis

Lourbopoulos, A; Deraos, G; Matsoukas, MT; Touloumi, O; Giannakopoulou, A; Kalbacher, H; Grigoriadis, N; Apostolopoulos, Vasso; Matsoukas, J

Cyclic MOG₃₅–₅₅ ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis

Download

[thumbnail of CyclicMOG_BMC_revised.pdf]

Preview

CyclicMOG_BMC_revised.pdf - Accepted Version (2MB) | Preview

Export

Lourbopoulos, A, Deraos, G, Matsoukas, MT, Touloumi, O, Giannakopoulou, A, Kalbacher, H, Grigoriadis, N, Apostolopoulos, Vasso ORCID: https://orcid.org/0000-0001-6788-2771 and Matsoukas, J (2017) Cyclic MOG₃₅–₅₅ ameliorates clinical and neuropathological features of experimental autoimmune encephalomyelitis. Bioorganic and Medicinal Chemistry, 25 (15). 4163 - 4174. ISSN 0968-0896

Dimensions Badge

Altmetric Badge

View Altmetric information about this item.

Item type	Article
URI	https://vuir.vu.edu.au/id/eprint/35379
DOI	10.1016/j.bmc.2017.06.005
Official URL	https://www.sciencedirect.com/science/article/pii/...
Subjects	Historical > FOR Classification > 1107 Immunology Current > Division/Research > College of Health and Biomedicine
Keywords	EAE; peptides; myelin oligodendrocyte glycoprotein; proteolipid protein; PLP
Citations in Scopus	14 - View on Scopus
Download/View statistics	View download statistics for this item